Three independent discounted-cash-flow-style models value Roivant Sciences Ltd. every trading day. 0 of 3 currently price ROIV above its market price.
| Free Cash Flow model | $-5.01 |
| Excess Profit model | $1.44 |
| Residual Earnings model | $5.61 |
| Dividend Discount model | — |
| Piotroski F-Score | 0 / 9 |
| Return on invested capital | -6.5% |
| Net debt / EBITDA | — |
| Gross margin | +84.4% |
| Revenue CAGR | -36.0% |
| Cash conversion | — |
| Dividend yield | — |
| Buyback yield | -3.5% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open ROIV in StockKitty